Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From AbbVie Inc.
Pharma pays $50m up front to tap insitro’s in vitro modeling technology, partners with Sensyne Health in blood disorders. Lilly’s COVID-19 partner AbCellera teams with Kodiak in ophthalmology R&D.
The firm’s major product revenues bounced back from the pandemic-troubled second quarter, with Botox recovering as predicted.
The global health crisis has presented a chance for the industry to improve its reputation by highlighting the value of its R&D engines. Pharma execs and observers talk to Scrip about why they are optimistic about industry’s chance to regain public trust.
Sponsors for the three marketed gene therapies discussed lessons learned about acceptance and uptake of cell and gene therapies.
- Other Names / Subsidiaries
- Pharmacyclics, Inc.
- Stemcentrx, Inc.